Insulin aspart, recombinant Subcutaneous and Nystatin (Oral)
Determining the interaction of Insulin aspart, recombinant Subcutaneous and Nystatin (Oral) and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: insulin aspart
Brand name: Fiasp, NovoLog, NovoLog FlexPen, NovoLog PenFill, NovoLOG FlexTouch, Fiasp PenFill, Fiasp FlexTouch
Synonyms: Insulin aspart, Insulin Aspart
Generic Name: nystatin
Brand name: Bio-Statin, Mycostatin
Synonyms: Nystatin
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Insulin aspart, recombinant Subcutaneous-Nystatin and Triamcinolone
- Insulin aspart, recombinant Subcutaneous-Nystatin and Triamcinolone Ointment
- Insulin aspart, recombinant Subcutaneous-Nystatin and triamcinolone topical
- Insulin aspart, recombinant Subcutaneous-Nystatin Oral Suspension
- Insulin aspart, recombinant Subcutaneous-Nystatin Powder for Oral Suspension
- Insulin aspart, recombinant Subcutaneous-Nystatin Tablets
- Nystatin (Oral)-Insulin degludec
- Nystatin (Oral)-Insulin Degludec (U-100) Prefilled Pens
- Nystatin (Oral)-Insulin Degludec (U-100) Vials
- Nystatin (Oral)-Insulin Degludec (U-200) Prefilled Pens
- Nystatin (Oral)-Insulin degludec and liraglutide
- Nystatin (Oral)-Insulin degludec and liraglutide Subcutaneous